| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -920 | -1,010 | -2,380 | -3,680 | 0 |
| Net Income Growth | +8.91% | +57.56% | +35.33% | unch | +100.00% |
Mosaic Immunoengineering (CPMV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company. It is focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. The company's product pipeline includes MI-O-101. Mosaic ImmunoEngineering Inc., formerly known as Patriot Scientific Corporation, is based in NOVATO, CA.
Fiscal Year End Date: 12/31